SCHEMBL5097699

SCHEMBL5097699

CCOC(=O)N(C)C(=O)Nc1cc(F)ccc1N1CCC(NC(=O)C2(NC(=O)c3ccco3)CCCCC2)C(O)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 5/20 0.35
TSHR P16473 3/20 0.35
NPSR1 Q6W5P4 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
OPRK1 P41145 1/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 3/20 0.34
SRPK1 Q96SB4 4/20 0.33
POLB P06746 3/20 0.33
KDM4E B2RXH2 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NTRK1 P04629 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5097702 0.87 POLB (0.47) MEN1KMT2AL3MBTL1ALDH1A1TSHR
SCHEMBL5105626 0.85 ALDH1A1 (0.38) KMT2AALDH1A1TSHRNPSR1HSD17B10
SCHEMBL5111723 0.83 ALDH1A1 (0.38) ALDH1A1TSHRNPSR1HSD17B10HPGD
SCHEMBL5098243 0.81 ALDH1A1 (0.37) ALDH1A1TSHRNPSR1HSD17B10HPGD
SCHEMBL5101585 0.81 MAPT (0.35) ALDH1A1TSHRNPSR1HSD17B10HPGD
SCHEMBL5105424 0.81 ALDH1A1 (0.38) ALDH1A1TSHRNPSR1HSD17B10HPGD
SCHEMBL5098552 0.80 ALDH1A1 (0.36) ALDH1A1TSHRNPSR1HSD17B10HPGD
SCHEMBL5101583 0.80 ALDH1A1 (0.34) ALDH1A1TSHRNPSR1HSD17B10HPGD
SCHEMBL5104866 0.79 ALDH1A1 (0.35) ALDH1A1TSHRNPSR1HSD17B10HPGD
SCHEMBL5097938 0.79 ALDH1A1 (0.42) KMT2AL3MBTL1ALDH1A1TSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342027-B2 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2008-03-11 US disclosed
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof DONG-A PHARMACEUTICAL CO., LTD. (KR) 2005-10-20 US disclosed
WO-2004011457-A1 1-PHENYLPIPERIDIN-3-ONE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2004-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234057-A1 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof CTRL, PRCP, CLPP MEN1 3518/4885KMT2A 4201/4885L3MBTL1 4450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.